Marshall Kadin | Profiles RNS

Marshall Kadin, MD

Voluntary Professor

Boston University Chobanian & Avedisian School of Medicine

Dermatology

MD, Northwestern University
BA, Northwestern University

Websites

	Roger Williams Medical Center
	ResearchGate
	LinkedIn

Dr. Marshall Kadin is a current Professor of Dermatology at the Chobanian and Avedisian School of Medicine. His current research involves investigating the role of cytokines in the pathogenesis of cutaneous T cell lymphomas.

Roger Williams Medical Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Glicksman C, McGuire P, Kadin M, Barnes K, Wixtrom R, Lawrence M, Haws M, Ferenz S, Sung J, Hamilton R, Faasse K. Longevity of Post-Explantation Systemic Symptom Improvement and Potential Etiologies: Findings From the ASERF Systemic Symptoms in Women - Biospecimen Analysis Study: Part 4. Aesthet Surg J. 2023 Apr 11. PMID: 37040435

McGuire P, Glicksman C, Wixtrom R, Sung CJ, Hamilton R, Lawrence M, Haws M, Ferenz S, Kadin M. Microbes, Histology, Blood Analysis, Enterotoxins, and Cytokines: Findings From the ASERF Systemic Symptoms in Women-Biospecimen Analysis Study: Part 3. Aesthet Surg J. 2023 Feb 03; 43(2):230-244. PMID: 35980942; PMCID: PMC9896138; DOI: 10.1093/asj/sjac225;

Kadin ME, Morgan J, Wei W, Song Z, Yang Y. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2023 Feb 03; 43(2):137-146. PMID: 35999655

Wei W, Song Z, Chiba M, Wu W, Jeong S, Zhang JP, Kadin ME, Nakagawa M, Yang Y. Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma. Leukemia. 2023 Feb; 37(2):396-407. PMID: 36456744; PMCID: PMC9949602; DOI: 10.1038/s41375-022-01774-z;

Wixtrom R, Glicksman C, Kadin M, Lawrence M, Haws M, Ferenz S, Sung J, McGuire P. Heavy Metals in Breast Implant Capsules and Breast Tissue: Findings from the Systemic Symptoms in Women-Biospecimen Analysis Study: Part 2. Aesthet Surg J. 2022 Aug 24; 42(9):1067-1076. PMID: 35474526; PMCID: PMC9400612; DOI: 10.1093/asj/sjac106;

Glicksman C, McGuire P, Kadin M, Lawrence M, Haws M, Newby J, Ferenz S, Sung J, Wixtrom R. Impact of Capsulectomy Type on Post-Explantation Systemic Symptom Improvement: Findings From the ASERF Systemic Symptoms in Women-Biospecimen Analysis Study: Part 1. Aesthet Surg J. 2022 Jun 20; 42(7):809-819. PMID: 34915566; PMCID: PMC9208825; DOI: 10.1093/asj/sjab417;

Kadin ME, Xu H, Hunsicker LM, Guan Y. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step? Aesthet Surg J. 2022 01 12; 42(2):NP125-NP129. PMID: 33944901

Kadin ME, Morgan J, Xu H, Glicksman C, Sieber D, Adams WP, McGuire P, Clemens MW, Thakur A, Lum LG. Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants. Aesthet Surg J. 2021 11 12; 41(12):1359-1364. PMID: 33165542; PMCID: PMC8842673; DOI: 10.1093/asj/sjaa302;

Mempin M, Hu H, Vickery K, Kadin ME, Prince HM, Kouttab N, Morgan JW, Adams WP, Deva AK. Gram-Negative Bacterial Lipopolysaccharide Promotes Tumor Cell Proliferation in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Cancers (Basel). 2021 Oct 22; 13(21). PMID: 34771464; PMCID: PMC8582399; DOI: 10.3390/cancers13215298;

Herrera A, Cheng A, Mimitou EP, Seffens A, George D, Bar-Natan M, Heguy A, Ruggles KV, Scher JU, Hymes K, Latkowski JA, Ødum N, Kadin ME, Ouyang Z, Geskin LJ, Smibert P, Buus TB, Koralov SB. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures. Blood. 2021 10 21; 138(16):1456-1464. PMID: 34232982; PMCID: PMC8532199; DOI: 10.1182/blood.2020009346;

Showing 10 of 302 results. Show More

Merlio JP, Kadin ME. Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas. Cancers (Basel). 2021 Aug 24; 13(17). PMID: 34503066; PMCID: PMC8428234; DOI: 10.3390/cancers13174256;

Stonesifer CJ, Grimes JM, Garcia-Saleem TJ, Niedt GW, Kadin ME, Geskin LJ. Stenotrophomonas maltophilia-associated primary cutaneous anaplastic large-cell lymphoma. JAAD Case Rep. 2021 Oct; 16:77-81. PMID: 34541271; PMCID: PMC8435984; DOI: 10.1016/j.jdcr.2021.08.006;

Du J, Zhao YT, Wang H, Zhang LX, Qin G, Zhuang S, Kadin M, Chin YE, Liu PY, Zhao TC. The Essential Role of PRAK in Preserving Cardiac Function and Insulin Resistance in High-Fat Diet-Induced Diabetes. Int J Mol Sci. 2021 Jul 27; 22(15).View Related Profiles.

Kadin, Marshall
Zhao, Ting

PMID: 34360761; PMCID: PMC8347374; DOI: 10.3390/ijms22157995;

Kadin ME. Commentary on: Analysis of the Molecular Signature of the Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient. Aesthet Surg J. 2021 04 12; 41(5):NP223-NP225. PMID: 33544150

Deva AK, Turner SD, Kadin ME, Magnusson MR, Prince HM, Miranda RN, Inghirami GG, Adams WP. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers (Basel). 2020 Dec 21; 12(12). PMID: 33371292; PMCID: PMC7765924; DOI: 10.3390/cancers12123861;

Vonderheid EC, Hamilton RG, Kadin ME. Mycosis Fungoides and Its Relationship to Atopy, Serum Total IgE, and Eosinophil Counts. Clin Lymphoma Myeloma Leuk. 2021 04; 21(4):279-288.e7. PMID: 33342729

Wang H, Wei W, Zhang JP, Song Z, Li Y, Xiao W, Liu Y, Zeng MS, Petrus MN, Thomas CJ, Kadin ME, Nakagawa M, Waldmann TA, Yang Y. A novel model of alternative NF-?B pathway activation in anaplastic large cell lymphoma. Leukemia. 2021 07; 35(7):1976-1989. PMID: 33184494; PMCID: PMC9245089; DOI: 10.1038/s41375-020-01088-y;

Di Napoli A, Greco D, Scafetta G, Ascenzi F, Gulino A, Aurisicchio L, Santanelli Di Pompeo F, Bonifacino A, Giarnieri E, Morgan J, Mancini R, Kadin ME. IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas. Cancer Immunol Immunother. 2021 May; 70(5):1379-1392. PMID: 33146828; PMCID: PMC8053183; DOI: 10.1007/s00262-020-02778-3;

Wen Y, Sun J, Yi S, Gao Y, Kouttab N, Morgan J, Wang Y, Kadin ME. IL-13 Signaling in CD30+ Cutaneous Lymphoproliferative Disorders. J Invest Dermatol. 2021 05; 141(5):1360-1363.e3. PMID: 33049271

Gao Y, Liu F, Sun J, Wen Y, Tu P, Kadin ME, Wang Y. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma. J Invest Dermatol. 2021 03; 141(3):607-618.e6. PMID: 32771472

Kadin ME, Morgan J, Kouttab N, Xu H, Adams WP, Glicksman C, McGuire P, Sieber D, Epstein AL, Miranda RN, Clemens MW. Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants. Aesthet Surg J. 2020 05 16; 40(6):630-637. PMID: 31589747

Kadin ME, Hamilton RG, Vonderheid EC. Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder. PLoS One. 2020; 15(2):e0228751. PMID: 32049976; PMCID: PMC7015403; DOI: 10.1371/journal.pone.0228751;

Hanson SE, Hassid VJ, Branch-Brooks C, Liu J, Kadin ME, Miranda R, Butler CE, Clemens MW. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2020 01 29; 40(2):149-153. PMID: 30789639

Kadin ME, Adams WP, Inghirami G, Di Napoli A. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder? Plast Reconstr Surg. 2020 01; 145(1):30e-38e. PMID: 31577659

Turner SD, Inghirami G, Miranda RN, Kadin ME. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Am J Pathol. 2020 01; 190(1):2-10. PMID: 31610171; PMCID: PMC7298558; DOI: 10.1016/j.ajpath.2019.09.005;

Vonderheid EC, Hamilton RG, Kadin ME. Prevalence of atopy and staphylococcal superantigen-specific immunoglobulin E (IgE) antibodies and total serum IgE in primary cutaneous T- and B-cell lymphoma. J Dermatol. 2019 Dec; 46(12):1170-1178. PMID: 31587349

Vonderheid EC, Kantor GR, Telang GH, Bujanouskas P, Kadin ME. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol. 2019 Dec; 46(12):913-924. PMID: 31403211

Kadin ME. Commentary on: A Case Report of a Breast Implant-Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant-Associated Neoplasms. Aesthet Surg J. 2019 06 21; 39(7):NP240-NP242. PMID: 31220209

Zhang JP, Song Z, Wang HB, Lang L, Yang YZ, Xiao W, Webster DE, Wei W, Barta SK, Kadin ME, Staudt LM, Nakagawa M, Yang Y. A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening. Blood. 2019 07 11; 134(2):171-185. PMID: 31151983; PMCID: PMC6624970; DOI: 10.1182/blood.2019001043;

Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, Jacobs HK, Zeng Y, Hundal T, Rech KL, Ketterling RP, Lee JH, Eckloff BW, Yan H, Gaonkar KS, Tian S, Ye Z, Kadin ME, Sidhu J, Jiang L, Voss J, Link BK, Syrbu SI, Facchetti F, Bennani NN, Slager SL, Ordog T, Kocher JP, Cerhan JR, Ansell SM, Feldman AL. Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma. Blood. 2019 06 27; 133(26):2776-2789. PMID: 31101622; PMCID: PMC6598380; DOI: 10.1182/blood.2019000626;

Mukhtar RA, Holland M, Sieber DA, Wen KW, Rugo HS, Kadin ME, Bean GR. Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications. Plast Reconstr Surg Glob Open. 2019 Apr; 7(4):e2188. PMID: 31321184; PMCID: PMC6554181; DOI: 10.1097/GOX.0000000000002188;

Kadin ME. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019 01 31; 39(Suppl_1):S28-S35. PMID: 30715174

Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP, Bacchi CE, Goes JCS, Clemens MW, Medeiros LJ, Miranda RN. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis. Hum Pathol. 2018 08; 78:54-62. PMID: 29689246

Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y. SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile. J Invest Dermatol. 2018 08; 138(8):1795-1804. PMID: 29510190

Yi S, Sun J, Qiu L, Fu W, Wang A, Liu X, Yang Y, Kadin ME, Tu P, Wang Y. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment. J Invest Dermatol. 2018 05; 138(5):1126-1136. PMID: 29248547

Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 09 01; 37(8):NP88-NP89. PMID: 29036946

Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493; DOI: 10.1093/asj/sjw286;

Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY. Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol. 2017 Sep; 92(9):892-901. PMID: 28543380; PMCID: PMC5546946; DOI: 10.1002/ajh.24794;

Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Jul; 44(7):616-619. PMID: 28337783; DOI: 10.1111/cup.12933;

Wang X, Dasari S, Nowakowski GS, Lazaridis KN, Wieben ED, Kadin ME, Feldman AL, Boddicker RL. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. Oncotarget. 2017 Apr 18; 8(16):26245-26255. PMID: 28412739; PMCID: PMC5432253; DOI: 10.18632/oncotarget.15441;

Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A. 2017 04 11; 114(15):3975-3980. PMID: 28356514; PMCID: PMC5393253; DOI: 10.1073/pnas.1700682114;

Maliniemi P, Laukkanen K, Väkevä L, Dettmer K, Lipsanen T, Jeskanen L, Bessede A, Oefner PJ, Kadin ME, Ranki A. Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. Oncoimmunology. 2017; 6(3):e1273310. PMID: 28405495; PMCID: PMC5384345; DOI: 10.1080/2162402X.2016.1273310;

Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol. 2017 Jun; 64:19-27. PMID: 28153507; PMCID: PMC5518937; DOI: 10.1016/j.humpath.2017.01.003;

Watanabe M, Nakano K, Kadin ME, Higashihara M, Watanabe T, Horie R. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells. Am J Pathol. 2017 Jan; 187(1):163-175. PMID: 27870927; DOI: 10.1016/j.ajpath.2016.09.007;

Battistella M, Janin A, Jean-Louis F, Collomb C, Leboeuf C, Sicard H, Bonnafous C, Dujardin A, Ram-Wolff C, Kadin ME, Bensussan A, Bagot M, Michel L. KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol. 2016 Aug; 175(2):325-33. PMID: 27037558; DOI: 10.1111/bjd.14626;

Ehrentraut S, Schneider B, Nagel S, Pommerenke C, Quentmeier H, Geffers R, Feist M, Kaufmann M, Meyer C, Kadin ME, Drexler HG, MacLeod RA. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Oncotarget. 2016 Jun 07; 7(23):34201-16. PMID: 27144517; PMCID: PMC5085149; DOI: 10.18632/oncotarget.9077;

Hu H, Johani K, Almatroudi A, Vickery K, Van Natta B, Kadin ME, Brody G, Clemens M, Cheah CY, Lade S, Joshi PA, Prince HM, Deva AK. Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016 Jun; 137(6):1659-69. PMID: 26890506; DOI: 10.1097/PRS.0000000000002010;

Andrique L, Poglio S, Prochazkova-Carlotti M, Kadin ME, Giese A, Idrissi Y, Beylot-Barry M, Merlio JP, Chevret E. Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines: A Useful Model for Rapid Biological and Therapeutic Evaluation. Am J Pathol. 2016 Jul; 186(7):1775-85. PMID: 27181405; DOI: 10.1016/j.ajpath.2016.03.012;

Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, Van Natta BW, Adams WP, Brody GS, Epstein AL. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016 Jul; 36(7):773-81. PMID: 26979456; DOI: 10.1093/asj/sjw023;

Vonderheid EC, Kadin ME, Telang GH. Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences. J Cutan Pathol. 2016 Apr; 43(4):303-12. PMID: 26566599; DOI: 10.1111/cup.12653;

Toda T, Watanabe M, Kawato J, Kadin ME, Higashihara M, Kunisada T, Umezawa K, Horie R. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines. Br J Haematol. 2015 Sep; 170(6):837-46. PMID: 26105086; DOI: 10.1111/bjh.13508;

Kadin ME. CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right. Br J Dermatol. 2015 Jun; 172(6):1478-9. PMID: 26036155; DOI: 10.1111/bjd.13808;

Guitart J, Martinez-Escala ME, Deonizio JM, Gerami P, Kadin ME. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes. J Am Acad Dermatol. 2015 Mar; 72(3):508-15. PMID: 25582534; DOI: 10.1016/j.jaad.2014.11.021;

Martinez-Escala ME, Sidiropoulos M, Deonizio J, Gerami P, Kadin ME, Guitart J. ?d T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous ?d T-cell lymphomas. Br J Dermatol. 2015 Feb; 172(2):372-9. PMID: 25143223; DOI: 10.1111/bjd.13364;

Wolk K, Mitsui H, Witte K, Gellrich S, Gulati N, Humme D, Witte E, Gonsior M, Beyer M, Kadin ME, Volk HD, Krueger JG, Sterry W, Sabat R. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clin Cancer Res. 2014 Nov 1; 20(21):5507-16. PMID: 25212608; DOI: 10.1158/1078-0432.CCR-14-0707;

Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Dal Maso L, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):1-14. PMID: 25174022; PMCID: PMC4155460; DOI: 10.1093/jncimonographs/lgu005;

Wang SS, Flowers CR, Kadin ME, Chang ET, Hughes AM, Ansell SM, Feldman AL, Lightfoot T, Boffetta P, Melbye M, Lan Q, Sampson JN, Morton LM, Zhang Y, Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):66-75. PMID: 25174027; PMCID: PMC4155466; DOI: 10.1093/jncimonographs/lgu012;

Aschebrook-Kilfoy B, Cocco P, La Vecchia C, Chang ET, Vajdic CM, Kadin ME, Spinelli JJ, Morton LM, Kane EV, Sampson JN, Kasten C, Feldman AL, Wang SS, Zhang Y. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):98-105. PMID: 25174030; PMCID: PMC4155463; DOI: 10.1093/jncimonographs/lgu008;

Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):130-44. PMID: 25174034; PMCID: PMC4155467; DOI: 10.1093/jncimonographs/lgu013;

Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, Wittig BM, Warszawska K, Kurek A, Erdmann-Keding M, Kunz S, Asadullah K, Kadin ME, Volk HD, Sterry W, Wolk K, Sabat R. IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol. 2014 Nov; 134(11):2757-67. PMID: 25046339; DOI: 10.1038/jid.2014.308;

Wang Y, Gu X, Zhang G, Wang L, Wang T, Zhao Y, Zhang X, Zhou Y, Kadin M, Tu P. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21. Blood. 2014 May 29; 123(22):3452-61. PMID: 24747435; DOI: 10.1182/blood-2013-10-534693;

Kadin ME, Hughey LC, Wood GS. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2014 Feb; 70(2):374-6. PMID: 24438952; DOI: 10.1016/j.jaad.2013.09.007;

Karai LJ, Kadin ME, Hsi ED, Sluzevich JC, Ketterling RP, Knudson RA, Feldman AL. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol. 2013 Aug; 37(8):1173-81. PMID: 23648461; DOI: 10.1097/PAS.0b013e318282d01e;

Vonderheid EC, Pavlov I, Delgado JC, Martins TB, Telang GH, Hess AD, Kadin ME. Prognostic factors and risk stratification in early mycosis fungoides. Leuk Lymphoma. 2014 Jan; 55(1):44-50. PMID: 23547839; DOI: 10.3109/10428194.2013.790541;

Ehrentraut S, Nagel S, Scherr ME, Schneider B, Quentmeier H, Geffers R, Kaufmann M, Meyer C, Prochorec-Sobieszek M, Ketterling RP, Knudson RA, Feldman AL, Kadin ME, Drexler HG, MacLeod RA. t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5. PLoS One. 2013; 8(1):e53767. PMID: 23372669; PMCID: PMC3553112; DOI: 10.1371/journal.pone.0053767;

Csikesz CR, Knudson RA, Greipp PT, Feldman AL, Kadin M. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22. J Invest Dermatol. 2013 Jun; 133(6):1680-2. PMID: 23337887; DOI: 10.1038/jid.2013.22;

Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood. 2012 Sep 13; 120(11):2280-9. PMID: 22855598; PMCID: PMC5070713; DOI: 10.1182/blood-2012-03-419937;

Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, Sposto R, Kadin ME, Hutchinson RJ, Nachman J. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group. J Clin Oncol. 2012 Sep 10; 30(26):3174-80. PMID: 22649136; PMCID: PMC3434976; DOI: 10.1200/JCO.2011.41.1819;

Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol. 2011 Dec; 33(8):835-40. PMID: 22042257; DOI: 10.1097/DAD.0b013e3181f4d8c3;

Watanabe M, Itoh K, Togano T, Kadin ME, Watanabe T, Higashihara M, Horie R. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma. Am J Pathol. 2012 Feb; 180(2):831-8. PMID: 22107829; PMCID: PMC4429177; DOI: 10.1016/j.ajpath.2011.10.007;

Kadin ME, Pavlov IY, Delgado JC, Vonderheid EC. High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. J Invest Dermatol. 2012 Mar; 132(3 Pt 1):703-10. PMID: 22071475; PMCID: PMC3278552; DOI: 10.1038/jid.2011.351;

Watanabe M, Nakano K, Togano T, Nakashima M, Higashihara M, Kadin ME, Watanabe T, Horie R. Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines. Oncol Res. 2011; 19(10-11):463-9. PMID: 22715589

Rathore B, Kadin ME. Hodgkin's lymphoma therapy: past, present, and future. Expert Opin Pharmacother. 2010 Dec; 11(17):2891-906.View Related Profiles.

Rathore, Bharti
Kadin, Marshall

PMID: 21050034; PMCID: PMC2978071; DOI: 10.1517/14656566.2010.515979;

Hirsch B, Braun FK, Al-Yacoub N, Assaf C, Kadin ME, Sterry W, Eberle J, Dürkop H. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells]. Pathologe. 2010 Oct; 31 Suppl 2:193-8. PMID: 20812013; DOI: 10.1007/s00292-010-1372-4;

Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010 Nov 18; 116(20):e90-8. PMID: 20699439; PMCID: PMC2993636; DOI: 10.1182/blood-2010-06-289561;

Kadin ME, Vonderheid EC. Targeted therapies: Denileukin diftitox--a step towards a 'magic bullet' for CTCL. Nat Rev Clin Oncol. 2010 Aug; 7(8):430-2. PMID: 20668480; DOI: 10.1038/nrclinonc.2010.105;

Kadin ME. Macrophages in Hodgkin's lymphoma. N Engl J Med. 2010 Jun 3; 362(22):2135-6; author reply 2136. PMID: 20527059

Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol. 2010 Jan; 18(1):16-23. PMID: 19550297; DOI: 10.1097/PAI.0b013e3181a307f7;

Kadin ME. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders. Oncology (Williston Park). 2009 Nov 30; 23(13):1158-64. PMID: 20043465

Braun FK, Hirsch B, Al-Yacoub N, Dürkop H, Assaf C, Kadin ME, Sterry W, Eberle J. Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol. 2010 Mar; 130(3):826-40. PMID: 19890350; DOI: 10.1038/jid.2009.299;

Mathas S, Kreher S, Meaburn KJ, Jöhrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dörken B. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A. 2009 Apr 7; 106(14):5831-6. PMID: 19321746; PMCID: PMC2667034; DOI: 10.1073/pnas.0900912106;

Kilbridge TM, Kadin ME. Teenager with hairy cell leukemia: 30-year follow-up. J Clin Oncol. 2009 Jan 1; 27(1):155-6. PMID: 19047276; DOI: 10.1200/JCO.2008.20.3372;

Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Am J Surg Pathol. 2008 Sep; 32(9):1421-6. PMID: 18670345; DOI: 10.1097/PAS.0b013e3181648d6d;

Fantin VR, Loboda A, Paweletz CP, Hendrickson RC, Pierce JW, Roth JA, Li L, Gooden F, Korenchuk S, Hou XS, Harrington EA, Randolph S, Reilly JF, Ware CM, Kadin ME, Frankel SR, Richon VM. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma. Cancer Res. 2008 May 15; 68(10):3785-94. PMID: 18483262; DOI: 10.1158/0008-5472.CAN-07-6091;

Rosenwald IB, Koifman L, Savas L, Chen JJ, Woda BA, Kadin ME. Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum Pathol. 2008 Jun; 39(6):910-6. PMID: 18234281; DOI: 10.1016/j.humpath.2007.10.021;

Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T, Okayasu I, Higashihara M, Horie R. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest. 2008 Jan; 88(1):48-57. PMID: 17965727

Staber PB, Vesely P, Haq N, Ott RG, Funato K, Bambach I, Fuchs C, Schauer S, Linkesch W, Hrzenjak A, Dirks WG, Sexl V, Bergler H, Kadin ME, Sternberg DW, Kenner L, Hoefler G. The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood. 2007 Nov 1; 110(9):3374-83. PMID: 17690253

Droc C, Cualing HD, Kadin ME. Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin. Cancer Control. 2007 Apr; 14(2):124-32. PMID: 17387297

Watanabe M, Dewan MZ, Taira M, Shoda M, Honda M, Sata T, Higashihara M, Kadin ME, Watanabe T, Yamamoto N, Umezawa K, Horie R. IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells. Lab Invest. 2007 Apr; 87(4):372-82. PMID: 17310217

Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet. 2007 Jan 1; 172(1):1-11. PMID: 17175373

Lones MA, Heerema NA, Le Beau MM, Perkins SL, Kadin ME, Kjeldsberg CR, Sposto R, Meadows A, Siegel S, Buckley J, Finlay J, Abromowitch M, Cairo MS, Sanger WG. Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet. 2006 Dec; 171(2):89-96. PMID: 17116485

Vonderheid EC, Kadin ME. Papular mycosis fungoides: a variant of mycosis fungoides or lymphomatoid papulosis? J Am Acad Dermatol. 2006 Jul; 55(1):177-80. PMID: 16781328

Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol. 2006 Feb; 33 Suppl 1:10-7. PMID: 16412208

Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME, Abraham LJ, Watanabe T, Horie R. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. Cancer Res. 2005 Sep 1; 65(17):7628-34. PMID: 16140928

Nachman J, Sposto R, Herzog P, Wolden S, Kadin M. Low dose involved field radiation (IFRT) or no further treatment following complete response to initial chemotherapy in young adult (YA) patients 16-21 years of age with Hodgkin's disease (HD): The Children's Cancer Group (CCG) Experience. J Clin Oncol. 2005 Jun; 23(16_suppl):8513. PMID: 27944597

Franchina M, Kadin ME, Abraham LJ. Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1322-5. PMID: 15894695

Greisser J, Doebbeling U, Roos M, Mueller B, Schmid M, Burg G, Kadin ME, Kempf W. Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol. 2005 May; 14(5):380-5. PMID: 15854132

Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol. 2004 Oct; 51(4):660-2. PMID: 15389210

Rübben A, Kempf W, Kadin ME, Zimmermann DR, Burg G. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol. 2004 Aug; 13(8):472-83. PMID: 15265011

Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME, Watanabe T. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma. Cancer Cell. 2004 Apr; 5(4):353-64. PMID: 15093542

Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley J, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Finlay J, Bergeron S, Cairo MS. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. J Pediatr Hematol Oncol. 2004 Mar; 26(3):169-78. PMID: 15125609

Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol. 2004 Mar; 140(3):306-12. PMID: 15023774

Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, Knaus P, Kadin ME. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor. Cancer Detect Prev. 2004; 28(1):57-64. PMID: 15041079

Dereure O, Levi E, Vonderheid EC, Kadin ME. Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis. Arch Dermatol. 2003 Dec; 139(12):1571-5. PMID: 14676072

Younes A, Kadin ME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol. 2003 Sep 15; 21(18):3526-34. PMID: 12972530

Watanabe M, Ogawa Y, Ito K, Higashihara M, Kadin ME, Abraham LJ, Watanabe T, Horie R. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am J Pathol. 2003 Aug; 163(2):633-41. PMID: 12875982; PMCID: PMC1868231

Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol. 2003 Jul; 40(3):244-56. PMID: 12876673

Willers J, Dummer R, Kempf W, Kündig T, Burg G, Kadin ME. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res. 2003 Jul; 9(7):2744-54. PMID: 12855655

Kadin ME. Genetic and molecular genetic studies in the diagnosis of T-cell malignancies. Hum Pathol. 2003 Apr; 34(4):322-9. PMID: 12733110

Kadin ME. Proceedings of the Boston workshop on cytogenetics and molecular genetics of hematologic malignancies, November 8 to 11, 2001: introduction. Hum Pathol. 2003 Apr; 34(4):305. PMID: 12733107

Burg G, Kempf W, Kazakov DV, Dummer R, Frosch PJ, Lange-Ionescu S, Nishikawa T, Kadin ME. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol. 2003 Mar; 148(3):580-6. PMID: 12653754

Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Müller-Hermelink HK, Paulli M, Wechsler J, Willemze R, Audring H, Bernengo MG, Cerroni L, Chimenti S, Chott A, Díaz-Pérez JL, Dippel E, Duncan LM, Feller AC, Geerts ML, Hallermann C, Kempf W, Russell-Jones R, Sander C, Berti E. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003 Feb 1; 97(3):610-27. PMID: 12548603

Kempf W, Kadin ME, Dvorak AM, Lord CC, Burg G, Letvin NL, Koralnik IJ. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis. 2003 Feb; 24(2):301-6. PMID: 12584181

Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003 Feb; 120(4):660-70. PMID: 12588354

Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL. Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol. 2003 Jan; 72(1):53-63. PMID: 12508269

Kleinhans M, Tun-Kyi A, Gilliet M, Kadin ME, Dummer R, Burg G, Nestle FO. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood. 2003 Feb 15; 101(4):1487-93. PMID: 12393570

Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol. 2002 Sep 15; 20(18):3765-71. PMID: 12228196

Willenbrock K, Ichinohasama R, Kadin ME, Miura I, Terui T, Meguro K, Fukuhara O, DeCoteau JF, Hansmann ML. T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction. Lab Invest. 2002 Sep; 82(9):1103-9. PMID: 12218070

Kadin ME. T-cell clonality in pityriasis lichenoides: evidence for a premalignant or reactive immune disorder? Arch Dermatol. 2002 Aug; 138(8):1089-90. PMID: 12164749

Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol. 2002 Jun; 118(6):949-56. PMID: 12060388

Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol. 2002 May 1; 20(9):2293-301. PMID: 11981000

Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M, Watanabe T. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol. 2002 May; 160(5):1647-54. PMID: 12000717; PMCID: PMC1850879

Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, Burg G, Kadin ME. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol. 2002 May; 29(5):295-300. PMID: 12100631

Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, Watanabe T. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene. 2002 Apr 11; 21(16):2493-503. PMID: 11971184

Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002 Apr; 16(4):594-600. PMID: 11960338

Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov; 37(5):432-41. PMID: 11745871

Kadin ME, Drews R, Samel A, Gilchrist A, Kocher O. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma. Hum Pathol. 2001 Nov; 32(11):1269-72. PMID: 11727269

Zhu D, Kadin ME, Samoszuk M. Detection of clonal T-cell receptor-gamma gene rearrangement by PCR/temporal temperature gradient gel electrophoresis. Am J Clin Pathol. 2001 Oct; 116(4):527-34. PMID: 11601137

Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. Ann N Y Acad Sci. 2001 Sep; 941:59-68. PMID: 11594583

Levi E, Pfeifer WM, Kadin ME. CD30-activation-mediated growth inhibition of anaplastic large-cell lymphoma cell lines: apoptosis or cell-cycle arrest? Blood. 2001 Sep 1; 98(5):1630-2. PMID: 11547770

Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001 Jul; 137(7):949-52. PMID: 11453817

Li S, Ross DT, Kadin ME, Brown PO, Wasik MA. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol. 2001 Apr; 158(4):1231-7. PMID: 11290540; PMCID: PMC1891906

Pantanowitz L, Saldinger PF, Kadin ME. Pathologic quiz case: Hepatic mass in a patient with renal cell carcinoma. Arch Pathol Lab Med. 2001 Apr; 125(4):577-8. PMID: 11260645

Kempf W, Kadin ME, Kutzner H, Lord CL, Burg G, Letvin NL, Koralnik IJ. Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol. 2001 Jan; 28(1):29-33. PMID: 11168749

Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S, Robison LL. Pesticide exposures in children with non-Hodgkin lymphoma. Cancer. 2000 Dec 1; 89(11):2315-21. PMID: 11147603

Levi E, Wang Z, Petrogiannis-Haliotis T, Pfeifer WM, Kempf W, Drews R, Kadin ME. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression. J Invest Dermatol. 2000 Dec; 115(6):1034-40. PMID: 11121138

Dereure O, Levi E, Kadin ME. T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000 Dec; 136(12):1483-6. PMID: 11115158

Kempf W, Margolin DH, Dezube BJ, Kadin ME, Letvin NL, Koralnik IJ. Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6. PMID: 11074559

Lones MA, Perkins SL, Sposto R, Kadin ME, Kjeldsberg CR, Wilson JF, Cairo MS. Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol. 2000 Nov 15; 18(22):3845-53. PMID: 11078498

Kadin ME. Cutaneous gamma delta T-cell lymphomas--how and why should they be recognized? Arch Dermatol. 2000 Aug; 136(8):1052-4. PMID: 10926743

Drews R, Samel A, Kadin ME. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg. 2000 Jun; 19(2):109-17. PMID: 10892712

Kadin ME. Regulation of CD30 antigen expression and its potential significance for human disease. Am J Pathol. 2000 May; 156(5):1479-84. PMID: 10793058; PMCID: PMC1876905

Murphy M, Signoretti S, Kadin ME, Loda M. Detection of TCR-gamma gene rearrangements in early mycosis fungoides by non-radioactive PCR-SSCP. J Cutan Pathol. 2000 May; 27(5):228-34. PMID: 10847547

Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M, Kadin ME, DeCoteau JF. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood. 2000 Mar 1; 95(5):1767-72. PMID: 10688836

Przybylski GK, Wu H, Macon WR, Finan J, Leonard DG, Felgar RE, DiGiuseppe JA, Nowell PC, Swerdlow SH, Kadin ME, Wasik MA, Salhany KE. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn. 2000 Feb; 2(1):11-9. PMID: 11272897; PMCID: PMC1906890

Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia. 2000 Jan; 14(1):169-82. PMID: 10637493

Signoretti S, Murphy M, Puddu P, DeCoteau JF, Faraggiana T, Kadin ME, Loda M. Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement. Diagn Mol Pathol. 1999 Dec; 8(4):176-82. PMID: 10617273

Mori M, Manuelli C, Pimpinelli N, Mavilia C, Maggi E, Santucci M, Bianchi B, Cappugi P, Giannotti B, Kadin ME. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression. Blood. 1999 Nov 1; 94(9):3077-83. PMID: 10556192

Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood. 1999 Oct 15; 94(8):2854-61. PMID: 10515889

Wang HH, Myers T, Lach LJ, Hsieh CC, Kadin ME. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Cancer. 1999 Oct 1; 86(7):1240-5. PMID: 10506709

Pfeifer W, Levi E, Petrogiannis-Haliotis T, Lehmann L, Wang Z, Kadin ME. A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1). Am J Pathol. 1999 Oct; 155(4):1353-9. PMID: 10514417; PMCID: PMC1867013

Ree HJ, Kadin ME, Kikuchi M, Ko YH, Suzumiya J, Go JH. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol. 1999 Apr; 30(4):403-11. PMID: 10208461

Signoretti S, Murphy M, Cangi MG, Puddu P, Kadin ME, Loda M. Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol. 1999 Jan; 154(1):67-75. PMID: 9916920; PMCID: PMC1853445

Kinney MC, Kadin ME. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol. 1999 Jan; 111(1 Suppl 1):S56-67. PMID: 9894470

Hodges KB, Collins RD, Greer JP, Kadin ME, Kinney MC. Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features. Am J Surg Pathol. 1999 Jan; 23(1):49-58. PMID: 9888703

Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998 Dec; 22(12):1528-37. PMID: 9850179

Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev. 1998 Dec; 7(12):1117-21. PMID: 9865430

Paulli M, Berti E, Boveri E, Kindl S, Bonoldi E, Gambini C, Rosso R, Borroni G, Straccapansa V, Magrini U, DeCoteau JE, Krammer PH, Möller P, Kadin ME. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. Hum Pathol. 1998 Nov; 29(11):1223-30. PMID: 9824099

Bhattacharyya N, Frankenthaler RA, Gomolin HI, Kadin ME, Lauretano AM. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck. Ann Otol Rhinol Laryngol. 1998 Sep; 107(9 Pt 1):801-6. PMID: 9749552

Ichinohasama R, Miura I, Funato T, Sato I, Suzuki C, Saito Y, Decoteau JF, Myers JB, Kadin ME, Sawai T, Ooya K. A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma. Cancer Genet Cytogenet. 1998 Jul 1; 104(1):19-27. PMID: 9648553

Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J, Kim DS. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol. 1998 Jun; 22(6):643-55. PMID: 9630171

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer. 1998 Jun; 22(2):114-21. PMID: 9598798

Ichinohasama R, Miura I, Shishido T, Matsumoto K, Shimizu Y, Miki T, DeCoteau JF, Kadin ME, Ooya K. Translocation (3;16)(q27;p11) in a patient with diffuse large B-cell lymphoma associated with the BCL-6 gene rearrangement. Cancer Genet Cytogenet. 1998 Jun; 103(2):133-9. PMID: 9614912

Butmarc JR, Kourea HP, Levi E, Kadin ME. Improved detection of CD5 epitope in formalin-fixed paraffin-embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval. Am J Clin Pathol. 1998 Jun; 109(6):682-8. PMID: 9620024

Kadin ME, Morris SW. The t(2;5) in human lymphomas. Leuk Lymphoma. 1998 Apr; 29(3-4):249-56. PMID: 9684923

Dubin DB, Hurowitz JC, Brettler D, Bernhard JD, Kadin ME, Wallace JE, Woda B, Pihan G, Kupper TS, Harrist TJ. Adnexotropic T-cell lymphoma presenting with generalized anhidrosis, progressive alopecia, pruritus, and Sjögren's syndrome. J Am Acad Dermatol. 1998 Mar; 38(3):493-7. PMID: 9520037

Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998 Jan 15; 91(2):717-23. PMID: 9427731

Rüdiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A, Harris NL, Kadin ME, MacLennan KA, Poppema S, Stein H, Weiss LE, Müller-Hermelink HK. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol. 1998; 9 Suppl 5:S31-8. PMID: 9926235

Ott G, Bastian BC, Katzenberger T, Decoteau JF, Kalla J, Rosenwald A, Weissinger F, Ott MM, Kadin ME, Müller-Hermelink HK. A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation. Br J Haematol. 1998 Jan; 100(1):187-90. PMID: 9450809

Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M, Younes A. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol. 1997 Dec; 99(3):618-24. PMID: 9401075

Ichinohasama R, DeCoteau JF, Myers J, Kadin ME, Sawai T, Ooya K. Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes. Leukemia. 1997 Nov; 11(11):1891-903. PMID: 9369423

Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997 Oct 15; 100(8):1969-79. PMID: 9329960; PMCID: PMC508386

Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PM. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 1997 Sep; 15(9):3060-6. PMID: 9294468

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E, Kadin M, Antin J. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Biol Blood Marrow Transplant. 1997 Jun; 3(2):98-106.View Related Profiles.

Antman, Karen
Kadin, Marshall

PMID: 9267670

DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, Kadin ME. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5877-81. PMID: 9159168; PMCID: PMC20874

Demierre MF, Goldberg LJ, Kadin ME, Koh HK. Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol. 1997 May; 36(5 Pt 1):765-72.View Related Profiles.

Goldberg, Lynne
Kadin, Marshall

PMID: 9146539

Butmarc J, Kourea HP, Kadin ME. CD5 immunostaining of lymphoid neoplasms in paraffin sections. Am J Clin Pathol. 1997 Apr; 107(4):496-7; author reply 497. PMID: 9124221

Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong WF, Xu Y, Mak TW, Kadin ME, Minden MD. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood. 1997 Apr 1; 89(7):2276-82. PMID: 9116269

Kadin ME. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv. 1997; 30:77-86. PMID: 9547987

Ichinohasama R, Miura I, Takahashi T, Yaginuma Y, Myers J, DeCoteau JF, Yee C, Kadin ME, Mori S, Sawai T. Peripheral CD4+ CD8- gammadelta T cell lymphoma: a case report with multiparameter analyses. Hum Pathol. 1996 Dec; 27(12):1370-7. PMID: 8958314

Gruss HJ, Kadin ME. Pathophysiology of Hodgkin's disease: functional and molecular aspects. Baillieres Clin Haematol. 1996 Sep; 9(3):417-46. PMID: 8922238

Wasik MA, Seldin DC, Butmarc JR, Gertz R, Marti R, Maslinski W, Kadin ME. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leuk Lymphoma. 1996 Sep; 23(1-2):125-36.View Related Profiles.

Seldin, David
Kadin, Marshall

PMID: 9021695

Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):9148-53. PMID: 8799169; PMCID: PMC38610

Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol. 1996 Aug; 149(2):469-81. PMID: 8701986; PMCID: PMC1865328

Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M, Kadin ME, Lodish HF. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol. 1996 Jul; 16(7):3480-9. PMID: 8668164; PMCID: PMC231343

Wasik MA, Sackstein R, Novick D, Butmarc JR, Zhang Q, Vonderheid EC, Kadin ME. Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2. Hum Pathol. 1996 Jul; 27(7):738-44. PMID: 8698322

Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin ME, Mori S, Sawai T. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report. Cancer. 1996 Jun 15; 77(12):2592-603. PMID: 8640711

DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996 Apr 15; 87(8):3437-41. PMID: 8605362

Crowson AN, Magro CM, Kadin ME, Stranc M. Differential expression of the bcl-2 oncogene in human basal cell carcinoma. Hum Pathol. 1996 Apr; 27(4):355-9. PMID: 8617478

Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol. 1996 Apr; 106(4):696-700. PMID: 8618007

Marti RM, Wasik MA, Kadin ME. Constitutive secretion of GM-CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder. Cytokine. 1996 Apr; 8(4):323-9. PMID: 9162223

Terenzi A, Bolognesi A, Pasqualucci L, Flenghi L, Pileri S, Stein H, Kadin M, Bigerna B, Polito L, Tazzari PL, Martelli MF, Stirpe F, Falini B. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Br J Haematol. 1996 Mar; 92(4):872-9. PMID: 8616080

Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996 Mar; 34(3):470-81. PMID: 8609262

Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol. 1996 Jan; 132(1):42-7. PMID: 8546482

Zirbel GM, Gellis SE, Kadin ME, Esterly NB. Lymphomatoid papulosis in children. J Am Acad Dermatol. 1995 Nov; 33(5 Pt 1):741-8. PMID: 7593772

Agnarsson BA, Kadin ME. Peripheral T-cell lymphomas in children. Semin Diagn Pathol. 1995 Nov; 12(4):314-24. PMID: 8578026

Resnik KS, Kantor GR, Lessin SR, Kadin ME, Chooback L, Cooper HS, Vonderheid EC. Mycosis fungoides palmaris et plantaris. Arch Dermatol. 1995 Sep; 131(9):1052-6. PMID: 7661607

DeCoteau JF, Kadin ME. New insights into peripheral T-cell lymphomas. Curr Opin Oncol. 1995 Sep; 7(5):408-14. PMID: 8541384

Piira T, Perkins SL, Anderson JR, Meadows AT, Chilcote RR, Kadin M, Kjeldsberg CR. Primary mediastinal large cell lymphoma in children: a report from the Childrens Cancer Group. Pediatr Pathol Lab Med. 1995 Jul-Aug; 15(4):561-70. PMID: 8597843

Cohen PL, Butmarc J, Kadin ME. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol. 1995 Jul; 104(1):50-3. PMID: 7611181

Tubergen DG, Krailo MD, Meadows AT, Rosenstock J, Kadin M, Morse M, King D, Steinherz PG, Kersey JH. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun; 13(6):1368-76. PMID: 7751881

Pasqualucci L, Wasik M, Teicher BA, Flenghi L, Bolognesi A, Stirpe F, Polito L, Falini B, Kadin ME. Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. Blood. 1995 Apr 15; 85(8):2139-46. PMID: 7718885

Peters K, Knoll JH, Kadin ME. Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis. Cancer Genet Cytogenet. 1995 Mar; 80(1):13-6. PMID: 7697626

Kadin ME. Pathology of Hodgkin's disease. Curr Opin Oncol. 1994 Sep; 6(5):456-63. PMID: 7827147

Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994 Jul; 103(1):34-41. PMID: 8027579

Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):6002-6. PMID: 8016105; PMCID: PMC44125

Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Am J Pathol. 1994 May; 144(5):1089-97. PMID: 8178932; PMCID: PMC1887350

Kadin ME. Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol. 1994 May; 12(5):884-7. PMID: 8164037

Tepler I, Schwartz G, Parker K, Charette J, Kadin ME, Woodworth TG, Schnipper LE. Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy. Cancer. 1994 Feb 15; 73(4):1276-85. PMID: 8313331

Sioutos N, Kerl H, Murphy SB, Kadin ME. Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol. 1994 Feb; 16(1):2-8. PMID: 8160926

Kadin ME. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol. 1994; 5 Suppl 1:25-30. PMID: 8172812

Finlay JL, Anderson JR, Cecalupo AJ, Hutchinson RJ, Kadin ME, Kjeldsberg CR, Provisor AJ, Woods WG, Meadows AT. Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552. Med Pediatr Oncol. 1994; 23(6):453-63. PMID: 7935170

Volkenandt M, Bertino JR, Shenoy BV, Koch OM, Kadin ME. Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma. J Dermatol Sci. 1993 Oct; 6(2):121-6. PMID: 8274457

Goldman BD, Oh SK, Davis BE, Kadin ME, Poiesz BJ, Koh HK. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment. Arch Dermatol. 1993 Sep; 129(9):1166-70. PMID: 8363402

Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993 Sep; 17(9):859-68. PMID: 8394652

Kadin ME, Vonderheid EC, Weiss LM. Absence of Epstein-Barr viral RNA in lymphomatoid papulosis. J Pathol. 1993 Jun; 170(2):145-8. PMID: 8393923

Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer. 1993 Mar 15; 71(6):2062-71. PMID: 8443755

Kadin ME. Lymphomatoid papulosis and associated lymphomas. How are they related? Arch Dermatol. 1993 Mar; 129(3):351-3. PMID: 8447675

Kadin M, Butmarc J, Elovic A, Wong D. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am J Pathol. 1993 Jan; 142(1):11-6. PMID: 8424449; PMCID: PMC1886832

Wang HH, Lach L, Kadin ME. Epidemiology of lymphomatoid papulosis. Cancer. 1992 Dec 15; 70(12):2951-7. PMID: 1451079

Hsu WT, Toporcer MB, Kantor GR, Vonderheid EC, Kadin ME. Cutaneous T-cell lymphoma with porokeratosis-like lesions. J Am Acad Dermatol. 1992 Aug; 27(2 Pt 2):327-30. PMID: 1517498

Sioutos N, Kadin ME. Perivascular Ki-1 + lesions. Int J Hematol. 1992 Jun; 55(3):275-9. PMID: 1498318

Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 1992 Apr 23; 326(17):1115-22. PMID: 1532439

Olerud JE, Kulin PA, Chew DE, Carlsen RA, Hammar SP, Weir TW, Patterson SD, Bolen JW, Kadin ME, Barker E, et al. Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol. 1992 Apr; 128(4):501-7. PMID: 1580657

Newcom SR, Tagra KK, Kadin ME. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta. Am J Pathol. 1992 Mar; 140(3):709-18. PMID: 1312308; PMCID: PMC1886176

Agnarsson BA, Vonderheid EC, Kadin ME. CD8+ cutaneous T-cell lymphoma. Am J Dermatopathol. 1991 Dec; 13(6):628-9. PMID: 1805657

Kadin ME. Unexpected finding--biologic truth or technical artifact? Hum Pathol. 1991 Oct; 22(10):941-3. PMID: 1842382

Kadin ME. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease. Semin Dermatol. 1991 Sep; 10(3):164-71. PMID: 1657104

Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink HK, Van Snick J, et al. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 1991 Sep 1; 78(5):1311-7. PMID: 1908723

Goldman BD, Bari M, Kantor GR, Kadin ME, Micaily B, Vonderheid EC. Cutaneous multilobated T-cell lymphoma with aggressive course. J Am Acad Dermatol. 1991 Aug; 25(2 Pt 2):345-9. PMID: 1894770

Kadin ME. Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity? J Clin Oncol. 1991 Apr; 9(4):533-6. PMID: 1648595

Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991 Feb 15; 77(4):799-808. PMID: 1847084

Su IJ, Wu YC, Chen YC, Hsieh HC, Cheng AL, Wang CH, Kadin ME. Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes. J Am Acad Dermatol. 1990 Oct; 23(4 Pt 1):653-62. PMID: 2229493

Vonderheid EC, Kang CA, Kadin M, Bigler RD, Griffin TD, Rogers TJ. Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations. J Am Acad Dermatol. 1990 Oct; 23(4 Pt 1):703-12. PMID: 2229499

Kadin ME, Said JW. Pathology of malignant lymphomas. Curr Opin Oncol. 1990 Oct; 2(5):822-31. PMID: 1965694

Kadin ME, Agnarsson BA, Ellingsworth LR, Newcom SR. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol. 1990 Jun; 136(6):1209-14. PMID: 2356855; PMCID: PMC1877568

Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol. 1990 Apr; 136(4):979-87. PMID: 1691596; PMCID: PMC1877642

Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990 Apr; 22(4):569-77. PMID: 2138636

Kadin ME. The Reed-Sternberg Cell, An Activated T-cell? The Evidence Has Come Full Circle. Leuk Lymphoma. 1990; 2(5):279-86. PMID: 27456917; DOI: 10.3109/10428199009106462;

Kadin ME. The spectrum of Ki-1+ cutaneous lymphomas. Curr Probl Dermatol. 1990; 19:132-43. PMID: 2153504

Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. 1989 Dec; 3(12):866-70. PMID: 2555633

Su IJ, Kadin ME. Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol. 1989 Sep; 135(3):439-45. PMID: 2789474; PMCID: PMC1879862

Agnarsson BA, Kadin ME. Host response in lymphomatoid papulosis. Hum Pathol. 1989 Aug; 20(8):747-52. PMID: 2787272

Agnarsson BA, Loughran TP, Starkebaum G, Kadin ME. The pathology of large granular lymphocyte leukemia. Hum Pathol. 1989 Jul; 20(7):643-51. PMID: 2661408

Sharpe RJ, Kadin ME, Harmon DC, Imber MJ, Anderson RR. Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides. J Am Acad Dermatol. 1989 Jun; 20(6):1123-4. PMID: 2754062

Agnarsson BA, Kadin ME. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues. Cancer. 1989 Jun 1; 63(11):2083-7. PMID: 2566368

Newcom SR, Kadin ME, Ansari AA, Diehl V. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. J Clin Invest. 1988 Dec; 82(6):1915-21. PMID: 2904450; PMCID: PMC442772

Newcom SR, Kadin ME, Phillips C. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell. Int J Cell Cloning. 1988 Nov; 6(6):417-31. PMID: 3230329

Su IJ, Balk SP, Kadin ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. Am J Pathol. 1988 Aug; 132(2):192-8. PMID: 2456698; PMCID: PMC1880737

Newcom SR, Kadin ME, Ansari AA. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol. 1988 Jun; 131(3):569-77. PMID: 2898211; PMCID: PMC1880714

Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol. 1988 Apr; 12(4):264-74. PMID: 3354752

Kadin ME, Said J. T-cell lymphomas and leukemias of post-thymic differentiation. Clin Lab Med. 1988 Mar; 8(1):135-50. PMID: 2896086

Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol. 1988 Feb; 130(2):345-53. PMID: 2963547; PMCID: PMC1880530

Aozasa K, Ueda T, Kurata A, Kim CW, Inoue M, Matsuura N, Takeuchi T, Tsujimura T, Kadin ME. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer. 1988 Jan 15; 61(2):309-15. PMID: 3334966

Agnarsson BA, Kadin ME. An unusual B-cell lymphoma simulating hairy cell leukemia. Am J Clin Pathol. 1987 Dec; 88(6):752-9. PMID: 3500633

Kadin ME. Histogenesis of Hodgkin's disease: possible insights from a comparison with lymphomatoid papulosis. Hum Pathol. 1987 Nov; 18(11):1085-8. PMID: 3500105

Muramoto LM, Kadin ME. Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). Am J Clin Pathol. 1987 Nov; 88(5):589-95. PMID: 2823597

Loughran TP, Starkebaum G, Clark E, Wallace P, Kadin ME. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol. 1987 Oct; 67(2):135-40. PMID: 3479187

Starkebaum G, Loughran TP, Kalyanaraman VS, Kadin ME, Kidd PG, Singer JW, Ruscetti FW. Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet. 1987 Mar 14; 1(8533):596-9. PMID: 2881134

Ree HJ, Kadin ME. The usefulness of peanut agglutinin for the detection of histiocytosis-X and interdigitating reticulum cells. Hum Pathol. 1987 Mar; 18(3):309-10. PMID: 3493200

Kadin ME, Vonderheid EC, Sako D, Clayton LK, Olbricht S. Clonal composition of T cells in lymphomatoid papulosis. Am J Pathol. 1987 Jan; 126(1):13-7. PMID: 3544850; PMCID: PMC1899539

Kadin ME. Cutaneous Ki-1 lymphoma: pathology, immunology and clinical characteristics. Princess Takamatsu Symp. 1987; 18:187-95. PMID: 3506541

Head DR, Kjeldsberg CR, Kadin ME, Pick T, Bybee B, Longbotham J, Shumski E. Childhood T-cell malignancy resembling adult T-cell leukemia/lymphoma. Hematol Pathol. 1987; 1(1):15-25. PMID: 3504428

Kadin ME. Characteristic immunologic profile of large atypical cells in lymphomatoid papulosis. Possible implications for histogenesis and relationship to other diseases. Arch Dermatol. 1986 Dec; 122(12):1388-90. PMID: 3024585

Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71. PMID: 3098093

Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986 Nov; 68(5):1042-9. PMID: 3490284

Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67. PMID: 3085703

Loughran TP, Kadin ME, Deeg HJ. T-cell intestinal lymphoma associated with celiac sprue. Ann Intern Med. 1986 Jan; 104(1):44-7. PMID: 3484421

Su IJ, Shih LY, Kadin ME, Dun P, Hsu SM. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia. Am J Clin Pathol. 1985 Dec; 84(6):715-23. PMID: 3000162

Kadin ME. Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet. 1985 Oct 19; 2(8460):864-5. PMID: 2413323

Wallis WJ, Loughran TP, Kadin ME, Clark EA, Starkebaum GA. Polyarthritis and neutropenia associated with circulating large granular lymphocytes. Ann Intern Med. 1985 Sep; 103(3):357-62. PMID: 4026084

Ree HJ, Kadin ME. Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease. Cancer. 1985 Jul 15; 56(2):333-8. PMID: 2408733

Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol. 1985 Jun; 119(3):436-47. PMID: 3893149; PMCID: PMC1888020

Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985 May; 119(2):315-25. PMID: 3158209; PMCID: PMC1887890

Bolen JW, Kadin ME. Cutaneous T-cell lymphoma with Reed-Sternberg cells: a light microscopic, immunocytochemical, and ultrastructural study. Ultrastruct Pathol. 1985; 9(3-4):225-31. PMID: 3879027

Foucar K, Carroll TJ, Tannous R, Peterson L, Goeken JA, Binion S, Gajl-Peczalska J, Kadin ME, Yokoyama WM. Nonendemic adult T-cell leukemia/lymphoma in the United States: report of two cases and review of the literature. Am J Clin Pathol. 1985 Jan; 83(1):18-26. PMID: 2981466

Mori N, Tsunoda R, Kojima M, Andres T, Kadin ME. Ultrastructural localization of immunoglobulins in hairy cell leukemia. Hum Pathol. 1984 Nov; 15(11):1042-7. PMID: 6436166

Kadin ME, Nasu K, Sako D, Su IJ. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia. Cancer Res. 1984 Aug; 44(8):3383-7. PMID: 6611200

Burstein SA, Malpass TW, Yee E, Kadin M, Brigden M, Adamson JW, Harker LA. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Br J Haematol. 1984 Jul; 57(3):383-92. PMID: 6743563

Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983 Sep; 14(9):745-72. PMID: 6350154

Sullivan KM, Neiman PE, Kadin ME, Dahlberg S, Farewell VT, Rudolph RH, Bagley CM, Appelbaum FR, Thomas ED. Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. Blood. 1983 Jul; 62(1):51-61. PMID: 6344932

Andres TL, Kadin ME. Immunologic markers in the differential diagnosis of small round cell tumors from lymphocytic lymphoma and leukemia. Am J Clin Pathol. 1983 May; 79(5):546-52. PMID: 6188365

Kadin ME, Kamoun M. Nonendemic adult T-cell leukemia/lymphoma. Hum Pathol. 1982 Aug; 13(8):691-3. PMID: 6980817

Kadin ME. Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep. 1982 Apr; 66(4):601-8. PMID: 6951633

Kim H, Pangalis GA, Payne BC, Kadin ME, Rappaport H. Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique. Am J Pathol. 1982 Feb; 106(2):204-23. PMID: 6950665; PMCID: PMC1916177

Kadin ME. T gamma cells: a missing link between malignant histiocytosis and T cell leukemia-lymphoma? Hum Pathol. 1981 Sep; 12(9):771-2. PMID: 6975747

Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med. 1981 Mar 12; 304(11):648-53. PMID: 6969851

Poore TE, Barrett SG, Kadin ME, Bainton DF. Ultrastructural localization of acid phosphatase in rosetted T and B lymphocytes of normal human blood. Am J Pathol. 1981 Jan; 102(1):72-83. PMID: 6970526; PMCID: PMC1903428

Kadin ME. Ia-like (HLA-DR) antigens in the diagnosis of lymphoma and undifferentiated tumors. Arch Pathol Lab Med. 1980 Oct; 104(10):503-508. PMID: 6998408

Kadin ME. A reappraisal of the Reed-Sternberg cell: a commentary. Blood Cells. 1980; 6(3):525-32. PMID: 6994843

Sybert VP, Setran KN, Kadin ME. Lymphocyte capping in carriers of Duchenne muscular dystrophy. N Engl J Med. 1979 Sep 27; 301(13):724-5. PMID: 481471

Newcom SR, Kadin ME. T-cell leukemia with thymic involution. Cancer. 1979 Feb; 43(2):622-6. PMID: 311242

Kadin ME, Stites DP, Levy R, Warnke R. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1978 Nov 30; 299(22):1208-14. PMID: 101841

Kadin ME, Billing RJ. B lymphocyte antigens in the differential diagnosis of human neoplasia. Blood. 1978 May; 51(5):813-23. PMID: 346089

Kadin M, Billing RJ. Immunofluorescent method for positive identification of null-cell type acute lymphocytic leukemias: use of heterologous antiserum. Blood. 1977 Nov; 50(5):771-82. PMID: 332257

Barrett SG, Schwade JG, Ranken R, Kadin ME. Lymphoblasts with both T and B markers in childhood leukemia and lymphoma. Blood. 1977 Jul; 50(1):71-9. PMID: 326316

Perkins HA, McIlroy M, Swanson J, Kadin M. Transient LW-negative red blood cells and anti-LW in a patient with Hodgkin's disease. Vox Sang. 1977; 33(5):299-303. PMID: 411256

Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr; 31(4):806-23. PMID: 4574662

Kadin ME, Asbury AK. Long term cultures of Hodgkin's tissue. A morphologic and radioautographic study. Lab Invest. 1973 Feb; 28(2):181-4. PMID: 4687527

Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF. Non-Hodgkin's lymphomas. II. Single agent chemotherapy. Cancer. 1972 Jul; 30(1):31-8. PMID: 4557278

Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer. 1971 Jun; 27(6):1277-94. PMID: 5088206

Kadin ME, Donaldson SS, Dorfman RF. Isolated granulomas in Hodgkin's disease. N Engl J Med. 1970 Oct 15; 283(16):859-61. PMID: 5458036

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 290 publications over 44 distinct years, with a maximum of 15 publications in 1996

Bar chart showing 290 publications over 44 distinct years, with a maximum of 15 publications in 1996

Year	Publications
1980	2
1981	3
1982	3
1983	3
1984	3
1985	8
1986	5
1987	9
1988	8
1989	6
1990	8
1991	7
1992	6
1993	7
1994	9
1995	9
1996	15
1997	10
1998	14
1999	9
2000	12
2001	9
2002	10
2003	12
2004	6
2005	4
2006	3
2007	5
2008	4
2009	3
2010	6
2011	4
2012	2
2013	4
2014	9
2015	4
2016	6
2017	9
2018	2
2019	8
2020	10
2021	7
2022	4
2023	3

Contact for Mentoring:

25 Buick St
Boston MA 02215
Google Map

401.456.2000

Download vCard

Kadin's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (867) concept(s)

Co-Authors

See all (4) people

Similar People

See all (60) people

Same Department

Search Department